SCHEMBL5956797

SCHEMBL5956797

N#Cc1ccc2c(c1)SCCCC2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
HTT P42858 1/20 0.44
MAOB P27338 5/20 0.41
MAOA P21397 3/20 0.41
VHL P40337 1/20 0.37
ELOC Q15369 1/20 0.37
ELOB Q15370 1/20 0.37
GRM5 P41594 3/20 0.37
PGR P06401 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HDAC4 P56524 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
HDAC3 O15379 1/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10363630 0.90 KDM4E (0.54) KDM4EHTTMAOBMAOAVHL
SCHEMBL10363955 0.78 VHL (0.58) KDM4EHTTMAOBMAOAVHL
SCHEMBL27766797 0.77 PNMT (0.42) MAOBMAOAHDAC4HDAC7HDAC8
SCHEMBL20165295 0.76 MAOA (0.54) KDM4EHTTMAOBMAOAVHL
SCHEMBL17495034 0.76 CASP1 (0.49) KDM4EHTTMAOBMAOAVHL
SCHEMBL5956746 0.76 KDM4E (0.47) KDM4EHTTMAOBMAOAVHL
SCHEMBL9636679 0.75 RYR2 (0.48) GRM5ALDH1A1HDAC4HDAC7HDAC8
SCHEMBL1091324 0.73 GRM5 (0.64) MAOBMAOAGRM5PGRCYP11B2
SCHEMBL29649348 0.73 GRM5 (0.64) MAOBMAOAGRM5PGRCYP11B2
SCHEMBL5956877 0.72 KDM4E (0.44) KDM4EHTTVHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270570-B1 AMIDE COMPOUNDS AND USE THEREOF MITSUBISHI PHARMA CORP (JP) 2006-05-31 EP disclosed
US-6933305-B2 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2005-08-23 US disclosed
US-20030158413-A1 Amide compounds and use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-08-21 US disclosed
EP-1270570-A1 AMIDE COMPOUNDS AND USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158413-A1 Amide compounds and use thereof ROCK2, ROCK1, RHOT2 KDM4E 1686/4885HTT 3077/4885MAOB 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.